2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad: 1st International Conference Held in San Francisco, California, May 2012 and 2nd International Conference Held in Indianapolis, Indiana, May 2013
January 2014
in “
British Journal of Sports Medicine
”
Studysummary This consensus statement discusses guidelines for screening, diagnosing, and treating the Female Athlete Triad, and introduces a risk stratification system to assist healthcare providers with sports participation decisions.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
In 2014, the Female Athlete Triad Coalition released a consensus statement on the treatment and return to play of the Female Athlete Triad, a condition seen in physically active women, characterized by low energy availability, menstrual dysfunction, and low bone mineral density. The statement provided clinical guidelines for healthcare providers and recommended a risk stratification point system for decision-making regarding sport participation. The panel emphasized the importance of a multidisciplinary healthcare team in diagnosing and treating the Triad. Non-pharmacological treatment strategies were suggested, primarily addressing low energy availability through diet and exercise modifications. If non-pharmacological treatments were unsuccessful after a year, pharmacological management was suggested. The panel also recommended lifestyle and behavioral changes, and optimal intake of calcium and vitamin D. The guidelines proposed a risk stratification system to determine clearance for participation in sports, with the team physician having the ultimate authority in the decision-making process.
